For sterile manufacturers, bioMérieux provides solutions for in-process microbial detection and final sterility testing, allowing companies to follow either PAT or pharmacopoeia compendial methods. From surface and personnel monitoring to air sampling, microbial detection and microbial limits testing, bioMérieux helps the pharmaceutical, biotech and advanced medicines industries manage microbiological risks and achieve compliance.
The BacT/ALERT 3D Dual T system is part of our solutions range and provides a rapid alternative to the compendial sterility test and can be used for in-process control and final product testing. An automated method providing non-destructive, continuous monitoring and objective reading, BacT/ALERT 3D Dual T provides a solution for  the sterility testing of short-shelf life, turbid products common to the advanced medicines sector, enabling sites to adhere to GMP requirements. BacT/ALERT 3D is already in routine use in autologous cell therapy, tissue and cord bank, vaccine manufacturing  and cell culture scale-up sites in the UK and Ireland and around the world.                                                                                                              bioMérieux provides solutions for Endotoxin testing with kits and automation using rFc-based assays and an end to end Low endotoxin recovery and de-masking protocol development service.
Visit our exhibition stand #47, (level 1) and discover bioMérieux’s complete range of solutions for managing the microbiological risks in advanced therapies and regenerative medicines.

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.